<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00231712</url>
  </required_header>
  <id_info>
    <org_study_id>133/04</org_study_id>
    <nct_id>NCT00231712</nct_id>
  </id_info>
  <brief_title>Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant</brief_title>
  <official_title>Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Julius-Maximilians University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Wuerzburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Julius-Maximilians University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct an analysis of the influences of

        1. conventional chemotherapy

        2. high-dose chemotherapy followed by autologous stem cell transplant

        3. high-dose chemotherapy followed by allogeneic stem cell transplant on the recovery of
           the immune system.

      Detailed analysis will help to better understand the pathways of recovery of the immune
      system following chemotherapy as well as the pathways of recovery of the immune system
      following autologous or allogeneic stem cell transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed analysis will be performed at preselected time points following therapy by

        -  standard flow cytometry in combination with intracellular cytokine/antigen staining

        -  spectratype analysis

        -  TREC assays
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2005</start_date>
  <completion_date>February 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>50</enrollment>
  <condition>Leukemia</condition>
  <condition>Medulloblastoma</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute leukemia treated according to current ALL-BFM 2002 protocol

          -  Solid tumor treated according to current GPOH-protocol

          -  Medulloblastoma treated according to HIT-2000 protocol

          -  High-dose chemotherapy followed by autologous stem cell transplantation

          -  High-dose chemotherapy followed by allogeneic stem cell transplantation

          -  Written consent according to our institutional guidelines

        Exclusion Criteria:

          -  No written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul G Schlegel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Pediatric Oncology Wuerzburg / Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthias Eyrich, MD</last_name>
    <role>Study Director</role>
    <affiliation>Pediatric Stem Cell Transplant Program</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul G Schlegel, MD</last_name>
    <phone>+49 - 931 - 201 - 27831</phone>
    <email>schlegel@mail.uni-wuerzburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beate Winkler, MD</last_name>
    <phone>49 - 931 - 201 - 27831</phone>
    <email>winkler_b@klinik.uni-wuerzburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Children's Hospital Pedaitric Oncology</name>
      <address>
        <city>Wuerzburg</city>
        <zip>D97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Winkler, MD</last_name>
      <phone>49 - 931 - 201 - 27831</phone>
      <email>winkler_b@klinik.uni.wuerzburg.de</email>
    </contact>
    <investigator>
      <last_name>Beate Winkler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Eyrich M, Wollny G, Tzaribaschev N, Dietz K, Br√ºgger D, Bader P, Lang P, Schilbach K, Winkler B, Niethammer D, Schlegel PG. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant. 2005 Mar;11(3):194-205.</citation>
    <PMID>15744238</PMID>
  </reference>
  <reference>
    <citation>Eyrich M, Leiler C, Lang P, Schilbach K, Schumm M, Bader P, Greil J, Klingebiel T, Handgretinger R, Niethammer D, Schlegel PG. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant. 2003 Aug;32(4):379-90.</citation>
    <PMID>12900774</PMID>
  </reference>
  <reference>
    <citation>Eyrich M, Croner T, Leiler C, Lang P, Bader P, Klingebiel T, Niethammer D, Schlegel PG. Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors. Blood. 2002 Sep 1;100(5):1915-8.</citation>
    <PMID>12176918</PMID>
  </reference>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2005</study_first_submitted>
  <study_first_submitted_qc>September 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2005</study_first_posted>
  <last_update_submitted>August 22, 2006</last_update_submitted>
  <last_update_submitted_qc>August 22, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2006</last_update_posted>
  <keyword>prospective analysis of immune function,</keyword>
  <keyword>spectratype</keyword>
  <keyword>immunoscope</keyword>
  <keyword>TREC analysis</keyword>
  <keyword>solid tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Medulloblastoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

